COMPANY PROFILE

Lonza

One of the leading global suppliers of active ingredients, chemical intermediates and biotechnology solutions to the pharmaceutical and agrochemical industries

Basel, SwitzerlandFounded 1897Biotech & Life Sciences

Valuation $34B Market cap · 2026

Revenue $7.13B Latest reported FY

EBITDA $1.29B Latest reported FY

About Lonza

In 1897, in the quaint Swiss village of Gampel, Albrecht Gansser and Dr. August Kleiber embarked on a venture that would eventually become a cornerstone of the pharmaceutical and biotechnology industries. They founded Lonza, named after the nearby river, initially focusing on producing electricity for the textile industry.

Over the decades, Lonza evolved, expanding its expertise and services. By the mid-20th century, the company had diversified into chemical manufacturing, setting the stage for its future as a leader in life sciences. This transformation was marked by strategic shifts and a commitment to innovation, allowing Lonza to adapt to the changing demands of the global market.

A pivotal moment in Lonza's history came in 1999 when the company went public, listing on the Swiss Stock Exchange. This move not only provided the capital needed for further expansion but also solidified Lonza's position as a key player in the global market.

Today, Lonza stands as a multinational powerhouse, providing critical development and manufacturing services to the pharmaceutical, biotechnology, and nutrition sectors. Its journey from a small Swiss town to a global leader underscores the impact of strategic foresight and adaptability in the ever-evolving landscape of life sciences.

MoreLess Source: Dealroom company data

At a glance

Status: Listed
Founded: 1897
Headquarters: Basel, Switzerland
Listing: IPO 1999
Employees: 19,417
Open positions: 493
Dealroom signal: 46.5/100
Industry: Health
Sub-industry: Pharmaceutical
Sector: Biotech & Life Sciences, Supply Chain Management, Tourism, Biotechnology, Chemistry, Horizon Europe, DT and LS
Business model: Manufacturing
Client focus: b2c
Investment activity: 14 companies, latest Oct 2025
Capital deployed: $120M
Preferred round: ACQUISITION
Links: Website LinkedIn X

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

5 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
POST IPO DEBT✓Debt	Apr 2024	$1.1B	—	Undisclosed	↗
POST IPO EQUITY✓Other financing	Jan 2024	$163M	—	SBI Mutual Fund	—

Showing the latest 2 of 5 recorded eventsBook a demo for the full funding history →

Financials

Revenue, earnings and profit over time

Revenue, earnings and other financial measures where available. Years marked “E” are estimates.

Year	Revenue	Growth	EBITDA	Margin	Profit	Margin	R&D
2026	$7.1B	+19.1%	$1.3B	18.1%	$870M	12.2%	$103M
2025	$6B	-0.7%	$1.3B	21.5%	$870M	14.5%	$103M
2024	$6B	-2.1%	$1.1B	17.5%	$583M	9.7%	$108M
2023	$6.2B	+7.9%	$840M	13.6%			$96M
2022	$5.7B	+266.1%	$1.8B	31%
2021	$1.6B	—	$1.2B	76.9%
2020	—	—	—	—	—	—

Company filings, research estimates and Dealroom dataBook a demo for the full financial model →

Growth signals

Lonza website traffic

Latest recorded traffic for Lonza is 240K monthly website visits, down 42.9% over the last three months. Lonza's team grew 47.6% over the past year.

Latest monthly visits240K 3-month web change-42.9% 1-year team growth+47.6%

Monthly website visitsOct 2014–Feb 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Open positions

Openings linked to this company in Dealroom

Senior Import/Export Logistics Trade AnalystVacaville, California, United States, Northern America, Americas · Logistics · Oct 5, 2026 Anlageingenieur 80-100% (m/w/d)38, Münchensteinerstrasse, St. Alban, Grossbasel, Basel, Basel-City, 4052, Switzerland · Accounting · Oct 5, 2026 R77028 Senior Manager, Account Management (Licensing)Cologne, Germany, Western Europe, Europe · Sales · Oct 5, 2026 Procurement & Sustainability Excellence Data and Systems SpecialistPuebla, Mexico, Central America, Americas · Data Science & Engineering · Oct 5, 2026 Head of Site Development and Support ServicesBasel, Switzerland, Western Europe, Europe · Project Management · Oct 5, 2026 Senior Manager, GE CQ AMERBend, Oregon, United States, Northern America, Americas · Project Management · Oct 5, 2026 Data Engineer – Process Analytics & Data Intelligence 80-100% (m/f/d)38, Münchensteinerstrasse, St. Alban, Grossbasel, Basel, Basel-City, 4052, Switzerland · Business Intelligence · Oct 5, 2026 Senior Graphic DesignerGurgaon, India, Southern Asia, Asia · Design · Oct 5, 2026

8 distinct openings shownExplore hiring signals →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
KTKintsugi TherapeuticsDevelopment of ER stress inhibitors for the treatment of metabolic diseases	Barcelona, Spain	Operational	2	$1.4M	$4.4M
SPSaudade PharmaSpecialized in pharmaceutical development and CMC of medicinal products	Montfoort, Netherlands	Operational
STSeekyo TherapeuticsA privately-owned biotech company developing a Smart Chemotherapy, selective to tumours, safe for patients	Saint-Maur-des-Fossés, France	Operational
TUTubulisGenerates uniquely matched protein-drug conjugates by combining proprietary novel technologies with disease-specific biology	Planegg, Germany	Acquired
CMCharnwood MolecularIntegrated drug discovery and development services provider	Loughborough, United Kingdom	Operational
AFAffichemAffichem - Drug Design, medical biotechnology company	Toulouse, France	Closed
LHLegacy HealthcareBiopharma developing innovative botanical drugs in supportive oncology care and dermatology	Epalinges, Switzerland	Operational
CYCytaCoatA unique and universal antimicrobial coating to prevent healthcare associated infections	Solna kommun, Sweden	Operational